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is underreported in TESS, most notably 
substance abuse and poisoning fatalities. 
During the quinquennium 1985–1990, 
about one-fifth of the calls to poison cent-
ers were not included in TESS,4 so the 
trends in the report might not be as robust 
as they might have been if data collection 
had been more universal. TESS data are 
collected during telephone consultations; 
thus, bedside confirmation and data col-
lection are not necessarily conducted by 
specialists in poison information. How-
ever, because calls are initiated by the 
general public, health-care professionals, 
and emergency first responders, the data 
collected provide a broader narrative of 
poisoning exposures than those from 
traditional health-care databases. Data 
quality may improve as data are collected 
and documented by specialists in poison 
information during the evaluation of the 
exposure and determination of the poten-
tial toxicity and therapeutic needs. It is 
also worth bearing in mind that the trend 
of the use of ECR in the United States may 
not necessarily reflect trends in Europe 
and the rest of the world.
Newer techniques for removal of toxins, 
such as Molecular Adsorbent Recirculat-
ing System (MARS), although still not 
widely available, may eventually become 
more common and replace HD as the 
modality of choice for removal of certain 
toxins. Efficacy of MARS in the removal 
of protein-bound drugs such as pheny-
toin, diltiazem, and theophylline has been 
described in case reports, but its availabil-
ity remains limited.
The epidemiological trend of extracor-
poreal toxin removal in the United States 
has been changing, as has the profile of 
drugs removed by these techniques. With 
the use of newer techniques and change in 
drugs used in medical therapy, the trends 
will continue to evolve, with nephrologists 
playing a central role in the use of these 
therapeutic modalities.
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Interstitial fibrosis:  
tubular hypothesis  
versus glomerular hypothesis
Erik I. Christensen1 and Pierre J. Verroust1
The pathogenesis of renal interstitial fibrosis leading eventually to renal 
failure is highly debatable. Whereas the so-called tubular hypothesis, 
involving an increased tubular uptake of potentially toxic substances 
that induce a variety of cytokines, growth factors, and profibrogenic 
factors, is based to a large extent on cell-culture studies, the glomerular 
hypothesis is based mainly on careful morphological observations. 
Unraveling the pathways appears to be extremely complex, but in vivo 
studies appear to offer the most reliable results.
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Most if not all glomerular diseases involv-
ing extracapillary injury progressively 
develop extensive fibrotic processes, lead-
ing to nephron destruction and terminal 
renal failure. Two hypotheses have been 
put forward to account for this evolution. 
The first proposes that the primary event 
is tubular: the increased amount of protein 
that gains access to the proximal tubule, 
which results in increased protein traffick-
ing in the proximal tubule cells, is toxic 
for the cells, thus triggering a number of 
inflammatory and fibrotic pathways. The 
second proposes that the primary event is 
glomerular: the formation of glomerular 
crescents leads to encroachment on the 
glomerular–tubular junction and subse-
quent tubular degeneration. Two recent 
studies provide additional data in this 
context.
Motoyoshi et al.1 (this issue) induced 
massive glomerular proteinuria in a 
mouse model, mating mosaic megalin 
kidney knockout mice with a transgenic 
mouse, NEP25, in which podocytes 
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expressing the transgene CD25 can be 
damaged by exposure to the immunotoxin 
LMB2 binding to CD25.2 Ten days after 
exposure to LMB2, these mice showed 
mild glomerular injury, and only 5% of 
the glomeruli showed modest to severe 
changes. Similarly, the mice showed mild 
tubulointerstitial changes with occasional 
tubule dilatation, protein casts, and rare 
fibrosis. The megalin-expressing cells 
preferentially accumulated albumin and 
immunoglobulin, and these cells also 
showed upregulation in the expression 
of the tubule injury markers heme oxy-
genase-1, monocyte chemoattractant 
protein-1 (MCP-1), and apoptosis. The 
inevitable conclusion of the authors is 
that the increased reabsorption of pro-
teins, notably high–molecular weight 
proteins, triggers events that can lead to 
tubule injury.
In a similar study, Theilig et al.3 reached 
an apparently opposite conclusion. In this 
study, glomerulonephritis was induced in 
mosaic kidney-specific megalin knockout 
mice by injection of anti-mouse glomeru-
lar basement membrane serum, and the 
mice were analyzed 18 days later. The 
mice developed crescentic glomerulone-
phritis and tubulointerstitial disease with 
tubular dilation and casts, but also with 
atrophy, degeneration, and collapse. From 
a morpho logical analysis, the authors 
concluded that the tubulointerstitial 
changes were related directly to glomeru-
lar changes extending into the proximal 
tubular junction. They also concluded that 
excessive uptake of protein in megalin-
expressing segments had no major impact 
on the development of tubulointerstitial 
disease. The authors suggested that the 
findings that cell proliferation and the 
inflammatory proteins transforming 
growth factor-β (TGF-β), intercellular 
adhesion molecule-1 (ICAM-1), vascu-
lar cell adhesion molecule-1 (VCAM-1), 
and endothelin-1 were increased in 
megalin-expressing cells might be due 
to stress-protective functions rather than 
disease-induced mechanisms.
Before we discuss the apparent dis-
crepancy between the two studies, it is 
worth taking a brief look at the arguments 
underlying each hypothesis.
The tubular hypothesis can be traced to 
a paper by Risdon and co-workers,4 who 
first showed in human renal biopsies 40 
years ago that progression to renal fail-
ure correlated more closely with tubular 
than with glomerular damage. Further 
evidence was derived from the close cor-
relation between the levels of proteinuria 
and disease progression (reviewed by 
Abbate et al.5). The bulk of evidence in 
favor of a toxic role of reabsorbed pro-
teins was obtained in vitro with the use 
of proximal tubular cells in culture. When 
exposed to a variety of plasma proteins, 
proximal tubular cells secrete cytokines 
such as endothelin-1, MCP-1, RANTES, 
interleukin-8, and fractalkine. Secreted 
cytokines appear to be released essentially 
at the basolateral pole, suggesting that 
they may indeed be involved in interstitial 
inflammation. They probably recruit and 
stimulate interstitial macrophages, which, 
under the influence of growth factors and 
profibrogenic factors such as TGF-β, 
transform interstitial cells into myofi-
broblasts. TGF-β may also be secreted by 
proximal tubular cells. The mechanisms 
of protein uptake have not been studied in 
detail, and, in particular, the expression of 
megalin and cubilin in cell-culture studies 
is often not documented. In contrast, the 
mechanisms involved in cytokine induc-
tion have been actively explored. Expo-
sure of various cells to albumin activates 
nuclear factor-κB (NF-κB) via a pathway 
involving protein kinase C−dependent 
generation of peroxide, mitogen-activated 
protein kinases (including p38, ERK1, and 
ERK2), and STAT. As Figure 15 illustrates, 
autocrine loops may exist, amplifying the 
inflammatory response. Finally, glomer-
ular-produced growth factors and/or 
cytokines may reach the tubule. In vitro, 
these cytokines upregulate their recep-
tors and induce basal secretion of MCP-1 
and RANTES. In vivo evidence relating 
increased protein trafficking to intersti-
tial inflammation and fibrosis is limited. 
Production of MCP-1 and activation of 
the NF-κB pathway have been described 
in five-sixths nephrectomy and passive 
Heymann’s nephritis. Similar observa-
tions have been reported in patients’ 
biopsies. It has also been reported that 
knockdown of key components of the 
putative pathway (for example, MCP-1 
or NF-κB) improved interstitial inflam-
mation. These experiments establish a 
link between interstitial inflammation 
and cytokine production, but they do 
not provide evidence directly linking 
these findings to proteinuria. The latter 
relies on pharmacological studies using 
angiotensin-converting enzyme inhibi-
tors, which decrease proteinuria, inhibit 
the production of MCP-1 and the activa-
tion of NF-κB, and limit the accumula-
tion of cells in the interstitium.
The glomerular hypothesis (reviewed 
by Kriz and LeHir6), sometimes referred 
to as the overload hypothesis, relies 
almost entirely on careful morphological 
analysis of various models of glomerular 
diseases. It proposes that inflammatory 
or degenerative processes of the glomeru-
lus invariably decrease podocyte density, 
resulting in naked areas of glomerular 
basement membrane to which parietal 
epithelial cells may adhere. Such adhe-
sions of the tuft to the glomerular capsule 
result in misdirected filtration through a 
podocyte-deprived filtration barrier. This 
results in the formation of the so-called 
proteinaceous crescents, which progres-
sively transform into cellular and fibro-
cellular crescents and encroach on the 
glomerular tubular junction, resulting 
in atubular glomeruli and aglomerular 
tubules (Figure 1).6 Also, misdirected 
ultrafiltration may indeed occur and dis-
sect tubular epithelial cells away from the 
tubular basement membrane. Key for this 
theory is the observation that a preserved 
tubule within damaged parenchymal and 
stromal tissue can be traced to a normal 
glomerulus. Dynamic experiments to 
further document this pathway are not 
easy to conceive. It has, however, been 
shown with the use of various tracers that 
misdirected ultrafiltration did occur.7
Of course, the two hypotheses are 
not mutually exclusive, and the objec-
tive at present is to define their role in 
a given pathological context. The paper 
by Motoyoshi et al.1 and the paper by 
Theilig et al.3 present data of significance 
in this context. First, both clearly show 
that megalin-dependent endocytosis 
significantly impacts the production 
of various markers of tubular injury, 
including proinflammatory/profibrotic 
components or adhesion molecules 
such as MCP-1 and heme oxygenase for 
Motoyoshi et al.1 and TGF-β, ICAM-1, 
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VCAM-1, and endothelin-1 for Theilig 
et al.3 This direct demonstration is 
important because previous studies 
relied on the antiproteinuric effects of 
angiotensin-converting enzyme inhibi-
tors, which, as was previously pointed 
out, may also prevent the non-hemody-
namic effects of angiotensin II on prox-
imal tubule cells, such as proliferation 
and TGF-β production.
Interestingly, the effects observed, nota-
bly on MCP-1, are not identical in the two 
studies. The reason for this is unknown. 
However, the experimental design of 
both papers does not give the authors the 
opportunity to relate the effects observed 
to the nature of the proteins internalized, 
which obviously varies depending on the 
type of glomerular lesion. Thus, albumin 
alone may be active, but components 
bound by albumin (free fatty acids, for 
instance) may also be important. It has 
also been proposed that transferrin had 
greater effects, and, perhaps most impor-
tant, that complement was essential.8,9 In 
addition, the cytokines, growth factors, 
and growth factor precursors that gain 
access to the proximal tubule will also 
vary with the type of glomerular lesion.
One important point in the study by 
Theilig et al.3 is the attempt to analyze 
both hypotheses in the same model. 
However the anti-glomerular basement 
membrane model selected is a rapidly 
progressive glomerulonephritis charac-
terized by the early formation of florid 
crescents. Such a model will obviously 
emphasize the glomerular hypothesis. In 
addition, the short course of the disease 
and the only partial inactivation of mega-
lin do not allow a full analysis of the tubu-
lar component. The study of Motoyoshi et 
al.,1 on the other hand, uses a model that 
should be more suitable, as the induction 
and the severity of the glomerular disease 
can be controlled. The study is limited by 
the short time span, the partial inactiva-
tion of megalin, and the minimal study of 
the glomerular lesions.
The question of whether tubulointer-
stitial changes induced by glomerular 
disease are a direct consequence of the 
glomerular disease spreading into the 
initial proximal tubule, causing obstruc-
tion of the proximal tubule and subse-
quent degeneration, or whether they are 
due to enhanced protein reab sorption 
and toxic effects on proximal tubule 
function inducing enhanced production 
of inflammatory proteins, has not been 
answered fully by these two studies. It 
is not possible, either, to conclude that 
the consequences of megalin-dependent 
protein endocytosis have a protective 
role. It is, however, interesting to note 
that Motoyoshi et al.1 found increased 
heme oxygenase-1 production, which is 
likely to protect tubules from the fibro-
genic effects of TGF-β. As an example, 
the complexity of the system is illustrated 
by the fact that heme oxygenase-1 acti-
vates NF-κB, which is generally con-
sidered pathogenic but may, in some 
instances, be protective.10 In our opinion, 
these papers can serve to design future 
experiments to specifically clarify the 
role of protein trafficking in the progres-
sion to renal failure. Carefully selected 
models of graded glomerular injury are 
available, and models of megalin and/
or cubilin inactivation are being devel-
oped. Because of the complex nature of 
the events, dissection of the influence of 
individual cytokines, growth factors, and 
so on will probably be best carried out 
with the use of one-by-one knock-in/
knockout animal models.
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Figure 1 | A highly simplified scheme of the two proposed mechanisms leading to 
progressive nephron degeneration. On the left, the increased ultrafiltered protein load triggers 
inflammatory and fibrogenic processes, destroying the tubule. Tubule cells and monocyte 
macrophages contribute to the fibrotic process. Autocrine loops may be formed. On the right, 
denuded basement membrane adheres to parietal epithelial cells, creating glomerular crescents 
that encroach on the glomerulotubular junction, leading to aglomerular tubules and atubular 
glomeruli. Abbreviations: C3aR, C3a receptor; TGF, transforming growth factor; TNF, tumor necrosis 
factor. (Adapted from refs. 5, 6.)
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